Results 11 to 20 of about 35,477 (203)

European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids. [PDF]

J Neuroendocrinol
Abstract This ENETS guidance paper, developed by a multidisciplinary working group, provides up‐to‐date and practical advice on the diagnosis and management of lung and thymic carcinoids, based on recent developments and study results. These recommendations aim to provide practical recommendations for the diagnosis, treatment and follow‐up of these ...
Baudin E, Durand A, Durand A, Buikhuisen W, Capdevila J, Caplin M, Deroose CM, Dromain C, Faggiano A, Filosso PL, Kaltsas G, Volante M, Walter T, Garcia-Carbonero R.   +13 more
europepmc   +2 more sources

Carcinoid heart disease: A case discussion with reappraisalcarcinoid heart disease: A case discussion with reappraisal

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2017
Carcinoid tumors are malignant neuroendocrine tumors arising from Kulchitsky cell. The most common site of primary carcinoid tumors is gastrointestinal tract (64%) followed by respiratory tract (28%).
Rohit Tandon, Ravinder Pal Singh
doaj   +1 more source

A novel mutation of the MEN1 gene in a patient with multiple endocrine neoplasia type 1 and recurrent fibromyxoid sarcoma – a case report

BMC Medical Genetics, 2020
Background Multiple endocrine neoplasia type 1 (MEN1) syndrome is usually accompanied by endocrine tumors, but non-endocrine tumors can occur as well. However, the coexistence of MEN1 syndrome and malignant tumor such as low-grade fibromyxoid sarcoma has
Maja Radman, Tanja Milicevic
doaj   +1 more source

Ectopic corticotroph syndrome [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2004
INTRODUCTION Endogenous Cushing's syndrome is a clinical state resulting from prolonged, inappropriate exposure to excessive endogenous secretion of Cortisol and hence excess circulating free cortisol, characterized by loss of the normal feedback ...
Penezić Zorana, Savić Slavica, Vujović Svetlana, Tatić Svetislav B., Ercegovac Maja, Drezgić Milka   +5 more
doaj   +1 more source

Hedinger Syndrome—Lessons Learnt: A Single-Center Experience

Journal of Cardiovascular Development and Disease, 2023
Background: Hedinger syndrome (HS) or carcinoid heart disease (CD) is a rare and challenging manifestation of malignant neuroendocrine tumours (NETs) involving the heart.
Mohamed El Gabry, Sven Arends, Sharaf-Eldin Shehada, Harald Lahner, Markus Kamler, Daniel Wendt, Konstantina Spetsotaki   +6 more
doaj   +1 more source

Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion [PDF]

, 1989
We investigated the molecular size of circulating immunoreactive ACTH by gel chromatography in patients with ACTH hypersecretion due to various disorders of the hypothalamic-pituitary-adrenal axis.
A Chatelain, AC Hale, B Allolio, B. Allolio, H Imura, JL Doppmann, JW Findling, K Nakao, M Reincke, M Reincke, M Thoren, M. Reincke, PJ Fuller, RC Pedersen, RE Mains, RS Yalow, SJ Ratter, U. Deuß, W. Winkelmann, Y Yamada   +19 more
core   +1 more source

Carcinoid syndrome due to a malignant somatostatinoma [PDF]

Postgraduate Medical Journal, 1995
Abstract Somatostatinoma is one of the rarest tumours of the endocrine pancreas. Cardinal manifestations of a somatostatinoma include gallstones, mild diabetes mellitus, steatorrhoea, diarrhoea and dyspepsia. Like any other pancreatic islet cell carcinoma, a somatostatinoma may also produce several different hormones such as ...
O, Ozbakir, F, Keleştimur, F, Oztürk, E, Sözüer, A, Unal, T E, Patiroğlu, K, Güven   +6 more
openaire   +4 more sources

Primary carcinoid tumors at atypical sites: surgery is mandatory and size determines survival—an Egyptian study

Bulletin of the National Research Centre, 2019
Background Carcinoids at atypical sites are rare and mostly asymptomatic. In the majority, they show normal levels of serotonin and its metabolites in plasma and urine, resulting in a relatively late diagnosis and hence guarded prognosis.
Karim G. Moustafa, Gamal M. Saied
doaj   +1 more source

Molecular pathogenesis and targeted therapy of sporadic pancreatic neuroendocrine tumors [PDF]

, 2015
Over the past few years, knowledge regarding the molecular pathology of sporadic pancreatic neuroendocrine tumors (PNETs) has increased substantially, and a number of targeted agents have been tested in clinical trials in this tumor type.
Ahn, Balogh, Bergers, Berruti, Capurso, Capurso, Carew, Castellano, Chamberlain, Chan, Chan, Chen, Clynes, Corbo, Corbo, Couvelard, De Wilde, Di Florio, Di Florio, Di Florio, Fazio, Fendrich, Gaur, Gurung, Han, Heaphy, Heaphy, Hobday, Hopfner, House, Jacinto, Jensen, Jiao, Karnik, Karnik, Komori, Kulke, Laplante, Loewith, Lovejoy, Luzi, Marinoni, Marion-Audibert, Mendel, Meric-Bernstam, Missiaglia, Mocellin, Panzuto, Papouchado, Passacantilli, Perren, Pàez-Ribes, Raymond, Sarbassov, Scoazec, Shah, Shi, Tang, Vinagre, Wang, Yang, Yao, Yuan, Zhang, Zhang   +64 more
core   +1 more source

High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report

Case Reports in Oncology, 2014
Pancreatic neuroendocrine tumors (NETs), including poorly differentiated carcinomas (NECs), are rarely encountered. The majority of these tumors do not secrete excess hormones, but functioning NETs produce large amounts of vasoactive peptides and may ...
Frank Van Fraeyenhove, Nathalie Meireson, Luc Terriere, Paul Willemsen, Jan Kunnen, Caroline Mattelaer, Frank Van Acker, Dirk Schrijvers   +7 more
doaj   +1 more source